Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby confirm the agreement by and among them to the joint filing on behalf of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of Greenway Medical Technologies, Inc., a Delaware corporation, and that this agreement may be included as an exhibit to such joint filing.
IN WITNESS WHEREOF, the undersigned hereby execute this Joint Filing Agreement as of October 3, 2013.
| | |
CRESTVIEW ACQUISITION CORP. |
| |
By: | | /s/ John Warnken-Brill |
Name: | | John Warnken-Brill |
Title: | | Attorney-in-Fact |
|
VCG HOLDINGS, LLC |
| |
By: | | /s/ John Warnken-Brill |
Name: | | John Warnken-Brill |
Title: | | Attorney-in-Fact |
|
VEPF IV AIV I, L.P. |
| |
By: | | /s/ John Warnken-Brill |
Name: | | John Warnken-Brill |
Title: | | Attorney-in-Fact |
|
VISTA EQUITY PARTNERS FUND IV GP, LLC |
| |
By: | | /s/ John Warnken-Brill |
Name: | | John Warnken-Brill |
Title: | | Attorney-in-Fact |
|
VEFIIGP, LLC |
| |
By: | | /s/ John Warnken-Brill |
Name: | | John Warnken-Brill |
Title: | | Attorney-in-Fact |
|
ROBERT F. SMITH |
| |
By: | | /s/ John Warnken-Brill |
Name: | | John Warnken-Brill |
Title: | | Attorney-in-Fact |